文献速递糖尿病

历史HbA1c值可解释2型糖尿病遗留效应:UKPDS 88

Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
PubMed 文献 · Diabetes Care · 2021-01-01

该研究基于3802名UKPDS参与者的20年数据,分析历史HbA1c值对全因死亡和心肌梗死风险的影响。结果显示,诊断时降低1%的HbA1c可在10-15年后使全因死亡风险降低18.8%,而延迟10年干预仅降低2.7%;心肌梗死风险降低分别为19.7%和6.5%。结论认为遗留效应主要由历史HbA1c值驱动,早期强化控糖至关重要。

要点

  • 诊断时即降低HbA1c比延迟10年干预能大幅降低远期全因死亡和心梗风险。
  • HbA1c对全因死亡的风险比随时间增加,20年时达1.36。
  • 早期检出糖尿病并从诊断起强化控糖是减少长期并发症的关键。

核心结论

  • 2型糖尿病的血糖遗留效应主要由历史HbA1c值而非近期值对临床结局的更大影响所解释。
  • 早期检出糖尿病并从诊断时开始强化血糖控制对最大化降低长期并发症风险至关重要。

研究设计与样本

  • 基于3802名UK Prospective Diabetes Study参与者的20年全因死亡和心肌梗死风险函数估计。
  • 分析随时间变化的HbA1c值,根据其对下游全因死亡和心梗风险的影响进行加权。

主要发现

  • HbA1c每升高1个百分点,全因死亡风险比在5年、10年、20年分别为1.08(95% CI 1.07-1.09)、1.18(1.15-1.21)、1.36(1.30-1.42)。
  • HbA1c每升高1个百分点,心肌梗死风险比在5年为1.13(1.11-1.15),20年增至1.31(1.25-1.36)。
  • 诊断时降低HbA1c 1个百分点,10-15年后全因死亡风险降低18.8%(95% CI 21.1-16.0);延迟10年干预仅降低2.7%(3.1-2.3)。
  • 诊断时降低HbA1c 1个百分点,心肌梗死风险降低19.7%(22.4-16.5);延迟10年干预降低6.5%(7.4-5.3%)。

临床怎么用

  • 对2型糖尿病患者应尽早开始强化血糖控制,以最大化降低远期全因死亡和心肌梗死风险。
  • 评估血糖控制时需重视历史HbA1c值的累积影响,而非仅关注近期水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes all-cause mortality (ACM) and myocardial infarction (MI) glycemic legacy effects have not been explained. We examined their relationships with prior individual HbA1c values and explored the potential impact of instituting earlier, compared with delayed, glucose-lowering therapy. RESEARCH DESIGN AND METHODS: Twenty-year ACM and MI hazard functions were estimated from diagnosis of type 2 diabetes in 3,802 UK Prospective Diabetes Study participants. Impact of HbA1c values over time was analyzed by weighting them according to their influence on downstream ACM and MI risks. RESULTS: Hazard ratios for a one percentage unit higher HbA1c for ACM were 1.08 (95% CI 1.07-1.09), 1.18 (1.15-1.21), and 1.36 (1.30-1.42) at 5, 10, and 20 years, respectively, and for MI was 1.13 (1.11-1.15) at 5 years, increasing to 1.31 (1.25-1.36) at 20 years. Imposing a one percentage unit lower HbA1c from diagnosis generated an 18.8% (95% CI 21.1-16.0) ACM risk reduction 10-15 years later, whereas delaying this reduction until 10 years after diagnosis showed a sevenfold lower 2.7% (3.1-2.3) risk reduction. Corresponding MI risk reductions were 19.7% (22.4-16.5) when lowering HbA1c at diagnosis, and threefold lower 6.5% (7.4-5.3%) when imposed 10 years later. CONCLUSIONS: The glycemic legacy effects seen in type 2 diabetes are explained largely by historical HbA1c values having a greater impact than recent values on clinical outcomes. Early detection of diabetes and intensive glucose control from the time of diagnosis is essential to maximize reduction of the long-term risk of glycemic complications.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lind M, Imberg H, Coleman RL, et al. Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 2021. PMID: 34244332. doi:10.2337/dc20-2439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。